Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Fujian Akeylink Biotechnology Co., Ltd.

Clinical trials sponsored by Fujian Akeylink Biotechnology Co., Ltd., explained in plain language.

Trials to join now! 1

New hope for hepatitis b patients when standard drugs fail

Disease control Recruiting now

This study is testing a new oral drug called Neracorvir (GST-HG141) for people with chronic hepatitis B who are still showing signs of the virus despite taking standard antiviral pills. Over 500 participants will be randomly assigned to receive either the new drug or a placebo, i…

Phase: PHASE3 • Sponsor: Fujian Akeylink Biotechnology Co., Ltd. • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC